You have 9 free searches left this month | for more free features.

Cancer of the Ovary

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Ovarian Cancer, Relapsed Ovarian Cancer, Fallopian Tube Cancer Trial (Carboplatin)

Not yet recruiting
  • Ovarian Cancer
  • +6 more
  • (no location specified)
Oct 27, 2022

Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

Recruiting
  • Ovarian Cancer
  • +68 more
  • Phoenix, Arizona
  • +8 more
Aug 18, 2022

Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary, Squamous Non-small-cell Lung Cancer Trial (VLS-1488)

Not yet recruiting
  • Advanced Solid Tumor
  • +15 more
  • (no location specified)
Jun 2, 2023

Marathon of Hope Cancer Centres Network Study for Ontario

Recruiting
  • Breast Cancer
  • +11 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Jun 6, 2022

    Blood Collection From People With Ovarian Cancer

    Completed
    • Ovarian Cancer
    • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Apr 7, 2022

      Ovarian Cancer, Surgery Trial in Pierre-Bénite (PROADAPT program)

      Recruiting
      • Ovarian Cancer
      • Surgery
      • PROADAPT program
      • Pierre-Bénite, France
        Service de Gériatrie, Centre Hospitalier Lyon Sud, 165 chemin du
      Jul 20, 2021

      Cancer, Risk of Premature Ovarian Failure, Fertility Preservation Trial in New York (surgery to remove ovaries or high dose

      Recruiting
      • Cancer
      • +2 more
      • surgery to remove ovaries or high dose chemotherapy
      • New York, New York
        Ronald O. Perelman and Claudia Cohen Center for Reproductive Med
      Jan 18, 2023

      Cancer, Solid Tumor, Solid Carcinoma Trial in Houston (AMXT1501, DFMO)

      Recruiting
      • Cancer
      • +18 more
      • Houston, Texas
        MD Anderson Cancer Center
      Aug 12, 2022

      Subjects Treated With Autologous T Cells Using Sleeping Beauty

      Not yet recruiting
      • Gynecologic Cancer
      • +9 more
      • Neoantigen specific TCR-T cell drug product
      • Houston, Texas
        MD Anderson Cancer Center
      Jul 27, 2022

      Cancer of Ovary, Endometrium Cancer, Cervix Cancer Trial in Trabzon (Logotherapy)

      Completed
      • Cancer of Ovary
      • +2 more
      • Logotherapy
      • Trabzon, Turkey (+90), Turkey
        Karadeniz Technical University
      Feb 8, 2022

      Malignant Tumor of Ovary, Malignant Tumor of Fallopian Tube, Malignant Tumor of Peritoneum Trial in Charlotte, Cleveland

      Completed
      • Malignant Neoplasm of Ovary
      • +2 more
      • Diagnostic laparoscopy
      • Charlotte, North Carolina
      • +1 more
      Mar 11, 2022

      Melanoma, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Trial in Australia (AI-061)

      Not yet recruiting
      • Melanoma
      • +16 more
      • Darlinghurst, New South Wales, Australia
      • +3 more
      May 12, 2023

      Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)

      Not yet recruiting
      • Solid Tumor, Adult
      • +19 more
      • A2B694
      • xT CDx with HLA-LOH Assay
      • Duarte, California
      • +9 more
      Sep 22, 2023

      Breast Carcinoma, Head Neck Cancer, Melanoma (Skin) Trial in Vandoeuvre-les-Nancy (Indocyanine green, Technetium99, Optonuclear

      Recruiting
      • Breast Carcinoma
      • +9 more
      • Indocyanine green
      • +3 more
      • Vandoeuvre-les-Nancy, France
        Institut de Cancérologie de Lorraine
      Mar 29, 2022

      Ovarian Cancer, Recurrent Cancer Trial (CYH33)

      Not yet recruiting
      • Ovarian Cancer
      • Recurrent Cancer
      • (no location specified)
      Sep 5, 2021

      Gynecologic Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Houston (Neoantigen specific TCR-T cell drug product,

      Recruiting
      • Gynecologic Cancer
      • +11 more
      • Neoantigen specific TCR-T cell drug product
      • Aldesleukin (IL-2)
      • Houston, Texas
        MD Anderson Cancer Center
      Jul 27, 2022

      Ovarian Cancer Trial in Milwaukee (Pembrolizumab, Carboplatin, Paclitaxel)

      Active, not recruiting
      • Ovarian Cancer
      • Milwaukee, Wisconsin
        Medical College of Wisconsin and Froedtert Hospital
      Apr 7, 2022

      Carcinosarcoma, Ovarian Trial in Oklahoma City (Galunisertib, Paclitaxel, Carboplatin)

      Active, not recruiting
      • Carcinosarcoma, Ovarian
      • Oklahoma City, Oklahoma
        Stephenson Cancer Center, University of Oklahoma Health Sciences
      Sep 27, 2021

      Lung Cancer, Liver Cancer, Colorectal Cancer Trial in Guangzhou (ipilimumab +pembrolizumab +durvalumab)

      Recruiting
      • Lung Cancer
      • +10 more
      • ipilimumab +pembrolizumab +durvalumab
      • Guangzhou, Guangdong, China
        The Second Affiliated Hospital of Guangzhou Medical University
      Jan 10, 2022

      Ovarian Cancer, Endometrial Cancer, Ovary Tumor Trial in Multiple Locations (Physician's choice according to patient's needs.)

      Recruiting
      • Ovarian Cancer
      • +6 more
      • Physician's choice according to patient's needs.
      • Multiple Locations, Germany
        Multiple sites all over Germany
      Dec 1, 2021

      Metastatic Cancer, Metastatic Breast Cancer, Metastatic Pancreatic Cancer Trial in Marseille (IPH5301 ALONE OR IN COMBINATION

      Recruiting
      • Metastatic Cancer
      • +8 more
      • IPH5301 ALONE OR IN COMBINATION WITH CHEMOTHERAPY AND TRASTUZUMAB
      • Marseille, France
        Institut Paoli Calmettes
      Feb 23, 2022

      Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Australia (ATX-101 + Carboplatin + Pegylated

      Recruiting
      • Ovarian Cancer
      • +3 more
      • ATX-101 + Carboplatin + Pegylated liposomal doxorubicin (ACD)
      • Blacktown, New South Wales, Australia
      • +5 more
      Nov 9, 2022

      Peritoneal Mesothelioma, Fallopian Tube Adenocarcinoma, Adenocarcinoma of the Ovary Trial in United States (MCY-M11,

      Terminated
      • Peritoneal Mesothelioma
      • +3 more
      • Rockville, Maryland
      • +3 more
      Aug 30, 2021

      Breast Cancer, Colorectal Cancer, Endometrial Cancer Trial in Birmingham, Memphis (Adapting MultiPLe Behavior Interventions That

      Recruiting
      • Breast Cancer
      • +8 more
      • Adapting MultiPLe Behavior Interventions That eFfectively Improve (AMPLIFI) Cancer Survivor Health
      • +3 more
      • Birmingham, Alabama
      • +1 more
      Feb 8, 2022